The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSant Uk.10te% Regulatory News (SAN)

Share Price Information for Sant Uk.10te% (SAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 147.75
Bid: 145.50
Ask: 150.00
Change: 0.00 (0.00%)
Spread: 4.50 (3.093%)
Open: 147.75
High: 147.75
Low: 147.75
Prev. Close: 147.75
SAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Announcement of Tender Offer

3 Jul 2012 14:50

RNS Number : 8244G
Santander UK Plc
03 July 2012
 



Santander UK plc Announces an Offer to Purchase for Cash Any and All of Certain Outstanding Term Subordinated Securities of Santander UK plc and Non-Cumulative Trust Preferred Securities of Abbey National Capital Trust I

July 3, 2012

Santander UK plc (formerly known as Abbey National plc) (the "Company") announces an offer (the "Offer") to holders of 7.95% Term Subordinated Securities due 2029 issued by of the Company (the 7.95% Securities) and 8.963% Non-Cumulative Trust Preferred Securities issued by Abbey National Capital Trust I (the "8.963% Securities," and together with the 7.95% Securities, the "Securities") to purchase for cash any and all such Securities for the tender offer consideration (the "Tender Offer Consideration") set forth in the table below. The Offer is being made upon the terms and subject to the conditions set forth in the offer to purchase dated July 3, 2012 (the "Offer to Purchase").

Title of Security

ISIN/CUSIP Numbers

Aggregate Principal Amount/Liquidation Preference Outstanding

Tender Offer Consideration Per US$1,000 Principal Amount/Liquidation Preference(1)

7.95% Term Subordinated Securities due 2029 issued by Abbey National plc

US002920AC09/002920AC0

US$1,000,000,000

US$1,060

8.963% Non-Cumulative Trust Preferred Securities issued by Abbey National Capital Trust I

US002927AA95/002927AA9

US$1,000,000,000

US$1,030

________________

(1) Does not include accrued, but unpaid interest or distributions, as applicable, which will be paid in addition to the Tender Offer Consideration.

The following is a brief summary of certain terms of the Offer:

·; Expiration Date: 5:00 p.m., New York City time, on July 12, 2012, unless extended or earlier terminated.

·; Tender Offer Consideration: US$1,060 per each US$1,000 principal amount of 7.95% Securities and US$1,030 per each US$1,000 liquidation preference of 8.963% Securities that are validly tendered and not validly withdrawn, and accepted for purchase by the Company pursuant to the terms in this Offer to Purchase.

·; Purpose of the Offer: The Offer, to the extent accepted, will enable the Company to enhance the quality of its capital structure through the generation of core tier one capital in the light of the regulatory changes expected to be introduced through the implementation of the Basel III accord. Any future decision by the Company as to the exercise of early redemption calls of its capital instruments will be made with reference to the economic impact for the Company of such early redemption, regulatory requirements and prevailing market conditions.

·; Accrued and Unpaid Interest and Distributions:  Holders who validly tender and do not validly withdraw their Securities and whose Securities are accepted for purchase in the Offer will also be paid a cash amount in US dollars equal to the accrued and unpaid interest in the case of the 7.95% Securities or accrued and unpaid distributions in the case of the 8.963% Securities from, and including, the immediately preceding interest payment date or distribution date, as applicable, up to, but excluding, the Settlement Date, payable on the Settlement Date.

·; Withdrawal Rights: Tendered Securities may be withdrawn any time prior to 5:00 p.m., New York City time, on July 12, 2012, unless extended or earlier terminated, but not thereafter, by Holders submitting a valid electronic withdrawal instruction as described in the Offer to Purchase.

·; Settlement Date for Offer: The Settlement Date will occur promptly after the Expiration Date. Assuming the Offer is not extended or earlier terminated, it is expected that the Settlement Date will be July 16, 2012.

·; Conditions to the Offer: Consummation of the Offer is conditioned upon the satisfaction or, where applicable, waiver of the conditions described in the Offer to Purchase.

Concurrently with the Offer, the Company is making an invitation to certain non-U.S. holders of other securities to offer to sell such securities to the Company. That invitation is not open to any holder of such securities that is a U.S. resident. U.S. residents that hold any such securities may not offer to sell them pursuant to such invitation.

For additional information regarding the terms of the Offer, please contact the Dealer Managers at Bank of America Merrill Lynch at +1-888-292-0070 (toll-free) or +1-980-683-3215 (collect) and Barclays at +1-800-438-3242 (toll-free) or +1-212-528-7581 (collect). Requests for documents and questions regarding the tendering of Notes may be directed to Lucid Issuer Services Limited at +44 207 704 0880 or santander@lucid-is.com.

Disclaimer

This announcement does not constitute an invitation to participate in the offer in or from any jurisdiction in or from which, or to or from any person to or from whom, it is unlawful to make such offer under applicable securities, blue sky or other laws. Nothing in this announcement constitutes an offer to buy or the solicitation of an offer to sell securities in:

(i) the United Kingdom (other than to investment professionals as defined in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the "Order"), or to persons within Article 43 of the Order, including existing members and creditors of the Company and any other persons to whom this electronic transmission can be lawfully communicated in circumstances where section 21(1) of the Financial Services and Markets Act 2000 does not apply);

(ii) the Republic of France (other than to providers of investment services relating to third party portfolio management and qualified investors (investisseurs qualifiés) all as defined in, and in accordance with, articles L.411-1, L.411-2 and D.441-1 to D.441-3 of the French Code monétaire et financier);

(iii) Belgium (other than "qualified investors" in the sense of Article 10 of the Belgian Law of June 16, 2006 on the public offer of placement instruments and the admission to trading of placement instruments on regulated markets (as amended or replaced from time to time), acting on their own account); or

(iv) any other jurisdiction in which such offer or solicitation would be unlawful.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLLFSVDTIVIIF
Date   Source Headline
7th May 201912:08 pmRNSDirectorate Change
2nd May 20194:45 pmRNSResult of AGM
1st May 20195:18 pmRNSNotice of AGM
30th Apr 201912:26 pmRNSPublication of Suppl.Prospcts
30th Apr 201912:21 pmRNSPublication of Suppl.Prospcts
23rd Apr 20193:39 pmRNSArticle 8
18th Apr 20194:18 pmRNSPublication of a Prospectus
17th Apr 20194:42 pmRNSDelisting notice Series 1141
17th Apr 20193:53 pmRNSNotice of Preference share redemption
27th Feb 20194:14 pmRNSPublication of Suppl.Prospcts
27th Feb 20194:06 pmRNSPublication of Suppl.Prospcts
27th Feb 20197:15 amRNSAnnual Financial Report
25th Feb 20194:12 pmRNSArticle 8
22nd Feb 20193:25 pmRNSNotice of Delisting 1139
12th Feb 20194:46 pmRNSPublication of Final Terms
30th Jan 20195:17 pmRNSPublication of Suppl.Prospcts
30th Jan 20194:53 pmRNSPublication of Suppl.Prospcts
30th Jan 20197:15 amRNSQ4 18 - Quarterly Management Statement
28th Dec 20184:49 pmRNSArticle 8
24th Dec 201812:15 pmRNSDelisting Announcement
13th Dec 20184:06 pmRNSDirectorate Change
28th Nov 20185:44 pmRNSStatement on the Outcome of 2018 BoE Stress Test
16th Nov 201811:45 amRNSNotice of Delisting 1067
16th Nov 201811:33 amRNSNotice of Delisting 1041
6th Nov 20183:51 pmRNSPublication of Suppl.Prospcts
6th Nov 20183:50 pmRNSPublication of Suppl.Prospcts
5th Nov 20184:22 pmRNSArticle 8
5th Nov 201812:04 pmRNSISE Delisting Announcement
1st Nov 201812:58 pmRNSForm 8.3 - NEX Group plc
31st Oct 20187:15 amRNS3rd Quarter Results
19th Oct 201810:57 amRNSForm 8.3 - NEX Group plc
12th Oct 20185:27 pmRNSNotice of Optional Redemption
9th Oct 20183:36 pmRNSNotice of Early Redemption
26th Sep 20183:39 pmRNSForm 8.3 - Shire plc
24th Sep 20181:37 pmRNSForm 8.3 - Shire plc
20th Sep 20184:24 pmRNSPublication of Final Terms
20th Sep 20183:49 pmRNSPublication of Final Terms
20th Sep 201811:25 amRNSForm 8.3 - NEX Group plc
19th Sep 201812:24 pmRNSForm 8.3 - NEX Group plc
19th Sep 201812:22 pmRNSForm 8.3 - Shire plc
10th Sep 20185:54 pmRNSPublication of Suppl.Prospcts
10th Sep 20184:58 pmRNSArticle 8
7th Sep 201812:48 pmRNS1132 NOTICE OF DELISTING
4th Sep 201811:53 amRNSForm 8.3 - Shire plc
3rd Sep 201812:39 pmRNSForm 8.3 - Shire plc
30th Aug 20185:11 pmRNSPublication of a Prospectus
30th Aug 20185:11 pmRNSPublication of a Prospectus
24th Aug 20184:56 pmRNSPublication of Suppl.Prospcts
21st Aug 20182:44 pmRNSForm 8.3 - Shire plc
17th Aug 20181:20 pmRNSForm 8.3 - NEX Group plc (Amendment)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.